Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
15.02
-0.32 (-2.09%)
Nov 20, 2024, 4:00 PM EST - Market closed
Assembly Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 28.33 | 7.16 | - | 6.25 | 79.11 | 15.96 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -92.09% | 395.55% | 7.83% | Upgrade
|
| Cost of Revenue | 52.66 | 48.9 | 69.08 | 70.15 | 101.34 | 85.32 | Upgrade
|
| Gross Profit | -24.33 | -41.74 | -69.08 | -63.9 | -22.23 | -69.36 | Upgrade
|
| Selling, General & Admin | 22.11 | 22.91 | 23.93 | 28.5 | 36.86 | 34.86 | Upgrade
|
| Operating Expenses | 22.11 | 22.91 | 23.93 | 28.5 | 36.86 | 34.86 | Upgrade
|
| Operating Income | -46.44 | -64.65 | -93.01 | -92.4 | -59.09 | -104.22 | Upgrade
|
| Interest & Investment Income | 6.07 | 3.45 | 1.02 | 0.3 | 2.62 | 4.31 | Upgrade
|
| EBT Excluding Unusual Items | -40.37 | -61.2 | -91.99 | -92.1 | -56.47 | -99.91 | Upgrade
|
| Merger & Restructuring Charges | - | - | -1.1 | 1.35 | -5.68 | -2.09 | Upgrade
|
| Impairment of Goodwill | - | - | - | -12.6 | - | - | Upgrade
|
| Asset Writedown | - | - | - | -0.04 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 3.6 | Upgrade
|
| Pretax Income | -40.37 | -61.2 | -93.09 | -132.39 | -62.15 | -98.41 | Upgrade
|
| Income Tax Expense | 0.44 | 0.03 | - | -2.53 | - | -0.77 | Upgrade
|
| Net Income | -40.8 | -61.23 | -93.09 | -129.86 | -62.15 | -97.63 | Upgrade
|
| Net Income to Common | -40.8 | -61.23 | -93.09 | -129.86 | -62.15 | -97.63 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 5 | 4 | 4 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 5 | 4 | 4 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 33.74% | 13.47% | 11.85% | 22.17% | 34.92% | 15.16% | Upgrade
|
| EPS (Basic) | -7.16 | -13.38 | -23.08 | -36.00 | -21.05 | -44.62 | Upgrade
|
| EPS (Diluted) | -7.16 | -13.38 | -23.08 | -36.00 | -21.05 | -44.62 | Upgrade
|
| Free Cash Flow | 22.84 | 22.49 | -84.57 | -96.49 | -63.43 | -85.62 | Upgrade
|
| Free Cash Flow Per Share | 4.01 | 4.91 | -20.96 | -26.75 | -21.48 | -39.13 | Upgrade
|
| Gross Margin | -85.90% | - | - | - | -28.10% | - | Upgrade
|
| Operating Margin | -163.94% | -902.50% | - | -1477.42% | -74.70% | -652.88% | Upgrade
|
| Profit Margin | -144.05% | -854.78% | - | -2076.35% | -78.57% | -611.63% | Upgrade
|
| Free Cash Flow Margin | 80.63% | 313.95% | - | -1542.88% | -80.18% | -536.37% | Upgrade
|
| EBITDA | -46.26 | -64.2 | -92.52 | -91.93 | -58.4 | -103.73 | Upgrade
|
| EBITDA Margin | -163.31% | - | - | - | -73.83% | - | Upgrade
|
| D&A For EBITDA | 0.18 | 0.45 | 0.5 | 0.47 | 0.69 | 0.49 | Upgrade
|
| EBIT | -46.44 | -64.65 | -93.01 | -92.4 | -59.09 | -104.22 | Upgrade
|
| EBIT Margin | -163.94% | - | - | - | -74.70% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.